Literature DB >> 35801080

Editorial: High-Throughput Sequencing-Based Investigation of Chronic Disease Markers and Mechanisms.

Yuriy L Orlov1,2,3,4, Wen-Lian Chen5, Marina I Sekacheva1, Guoshuai Cai6, Hua Li7.   

Abstract

Entities:  

Keywords:  biomarker development; chronic disease; disease mechanism; high-throughput sequencing; omics study; prognosis prediction

Year:  2022        PMID： 35801080      PMCID： PMC9253685          DOI： 10.3389/fgene.2022.922206

Source DB:  PubMed          Journal:  Front Genet        ISSN： 1664-8021            Impact factor:   4.772


× No keyword cloud information.
  9 in total

1.  Computational genomics at BGRS\SB-2016: introductory note.

Authors:  Yuriy L Orlov; Ancha V Baranova; Ralf Hofestädt; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

2.  Editorial: Association Between Individuals' Genomic Ancestry and Variation in Disease Susceptibility.

Authors:  Ranajit Das; Tatiana V Tatarinova; Elvira R Galieva; Yuriy L Orlov
Journal:  Front Genet       Date:  2022-02-02       Impact factor: 4.599

3.  Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma.

Authors:  Veronika Voronova; Peter Glybochko; Andrey Svistunov; Viktor Fomin; Philipp Kopylov; Peter Tzarkov; Alexey Egorov; Evgenij Gitel; Aligeydar Ragimov; Alexander Boroda; Elena Poddubskaya; Marina Sekacheva
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

4.  Recent Trends in Cancer Genomics and Bioinformatics Tools Development.

Authors:  Anastasia A Anashkina; Elena Y Leberfarb; Yuriy L Orlov
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

5.  Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method.

Authors:  Alexander Glukhov; Natalya Potoldykova; Mark Taratkin; Sergey Gordeev; Konstantin Polyakovsky; Ekaterina Laukhtina; Marco Moschini; Mohammad Abufaraj; Shahrokh F Shariat; Marina Sekacheva; Dmitry Enikeev; Petr Glybochko
Journal:  J Clin Med       Date:  2021-03-04       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.